Tavistock Investments
TAVI · AIM · Financial Services · mcap £9.0m · 2.0p
- Revenue
- £23.2m
- Operating profit
- −£8.1m
- Net income
- −£8.6m
- Free cash flow
- −£6.1m
- Net cash
- £4.5m
- Market cap
- £9.8m
- EV / EBIT
- –
- FCF yield
- −61.8%
- Price / book
- 0.3×
- Revenue
- £11.1m −43%
- Operating profit
- −£1.1m prior −£188k
- Net income
- −£1.8m prior −£989k
- Cash from operations
- −£3.7m –
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Results for the year ended 31 March 2026, published 24 Sep 26 · read the announcement ↗
Consolidated Statement of Comprehensive Income · For the year ended 31 March 2026
| 31 March 2026 £'000 | 31 March 2025 £'000 | |
|---|---|---|
| Revenue | 23,170 | 32,628 |
| Cost of sales | (14,517) | (19,882) |
| Gross profit | 8,653 | 12,746 |
| Administrative expenses | (16,770) | (23,061) |
| Gain on Sale | - | 20,032 |
| (Loss)/Profit from Total Operations | (8,117) | 9,717 |
| MEMORANDUM ONLY- Adjusted EBITDA | (2,099) | 1,761 |
| Depreciation & amortisation 10&11 | (1,048) | (3,941) |
| Impairment to goodwill and other intangibles | (52) | (234) |
| Share based payments | (64) | 446 |
| Share based buybacks | - | (213) |
| Write off irrecoverable trade receivables | (591) | (144) |
| Gain on reassessment of recoverable amount of receivable | 400 | - |
| Gain on sale of subsidiary | - | 20,032 |
| Subsidiary LLP members remuneration as an expense | (1,250) | (1,356) |
| Other non-recurring costs | (3,413) | (6,635) |
| (Loss)/Profit from Operations | (8,117) | 9,717 |
| Net finance expense | (420) | (339) |
| Impairment of investment in associate | - | (2,679) |
| (Loss)/Profit before taxation | (8,537) | 6,699 |
| Taxation charge | (15) | (1) |
| (Loss)/Profit after taxation and attributable to equity holders of the parent and total comprehensive income for the year | (8,552) | 6,698 |
| (Loss)/Profit per share | ||
| Basic | (1.53)p | 1.20p |
| Diluted | (1.35)p | 1.06p |
Consolidated Statement of Financial Position · As at 31 March 2026
| 31 March 2026 £'000 | 31 March 2025 (Restated) £'000 | |
|---|---|---|
| ASSETS | ||
| Non-current assets | ||
| Intangible assets | 20,838 | 20,599 |
| Tangible fixed assets | 1,082 | 754 |
| Trade and other receivables | 1,916 | 7,500 |
| Total non-current assets | 23,836 | 28,853 |
| Current assets | ||
| Trade and other receivables | 10,560 | 17,984 |
| Cash and cash equivalents | 9,241 | 7,403 |
| Total current assets | 19,801 | 25,387 |
| Total assets | 43,637 | 54,240 |
| LIABILITIES | ||
| Current liabilities | ||
| Trade and other payables | (2,907) | (5,909) |
| Borrowings | (1,857) | (1,136) |
| Lease liabilities | (352) | (352) |
| Provisions | (2,047) | (1,063) |
| Total current liabilities | (7,163) | (8,459) |
| Non-current liabilities | ||
| Borrowings | (2,876) | (4,183) |
| Lease liabilities | (698) | (169) |
| Other payables | (34) | (686) |
| Deferred taxation | - | (1) |
| Provisions | (2,488) | (1,502) |
| Total non-current liabilities | (6,096) | (6,541) |
| Total liabilities | (13,259) | (15,000) |
| Total net assets | 30,378 | 39,240 |
| Capital and Reserves | ||
| Share Capital | 5,602 | 5,602 |
| Treasury Shares | (5,798) | (5,798) |
| Share Premium | 1,828 | 1,828 |
| Capital Redemption Reserve | 534 | 534 |
| Retained Earnings | 28,212 | 37,074 |
| Total equity | 30,378 | 39,240 |
Consolidated Statement of Cash Flows · For the year ended 31 March 2026
| 31 March 2026 £'000 | 31 March 2025 (Restated) £'000 | |
|---|---|---|
| Cash flow from operating activities | ||
| Profit/(Loss) before taxation | (8,537) | 6,699 |
| Adjustments for | ||
| Share based payments | 64 | (234) |
| Depreciation of tangible fixed assets | 648 | 605 |
| Amortisation of intangible assets | 400 | 3,336 |
| Write off other receivables | - | 8,912 |
| Write off irrecoverable trade receivables | 591 | - |
| Net finance expense | 420 | 339 |
| Impairment of intangible assets | 52 | - |
| Gain on sale of subsidiary entities | - | (20,032) |
| Cash flows from operating activities before changes in working capital | (6,362) | (375) |
| Decrease/(increase) in trade and other receivables | 582 | (4,730) |
| (Decrease)/Increase in trade and other creditors | (1,168) | 461 |
| Increase/(decrease) in provisions | 1,972 | - |
| Cash used in Operations | (4,976) | (4,644) |
| Investing activities | ||
| Purchase of client lists and internally developed assets | (592) | (1,386) |
| Purchase of tangible fixed assets | (40) | (53) |
| Increase in interest in controlled subsidiary | - | (550) |
| Deferred consideration payments | (1,390) | (705) |
| Return of capital from investment | 1,930 | - |
| New loans issued | (25) | - |
| Payment for acquisition of subsidiary, net of cash acquired | - | (6,383) |
| Cash received on sale of subsidiary entities | 9,448 | 21,360 |
| Net cashflow used from investing activities | 9,331 | 12,283 |
| Financing activities | ||
| Net interest paid | (420) | (339) |
| New leases | - | 30 |
| Lease principal repayments | (447) | (588) |
| Loan repayments | (1,209) | (742) |
| New loans received | - | 3,275 |
| Repurchase of own shares | - | (5,798) |
| Share based buybacks | - | 213 |
| Dividend payment | (441) | (405) |
| Net cashflow from financing activities | (2,517) | (4,354) |
| Net change in cash and cash equivalents | 1,838 | 3,285 |
| Cash and cash equivalents at start of the year | 7,403 | 4,118 |
| Cash and cash equivalents at end of the year | 9,241 | 7,403 |
| Movement in net debt | ||
| 31 March 2026 31 March 2025 | ||
| £'000 £'000 | ||
| Net increase/(decrease) in cash and cash equivalents | 1,838 | 3,285 |
| New loans liability | (623) | (3,275) |
| New lease liability | (976) | (30) |
| Lease repayment | 447 | 588 |
| Loan repayment | 1,209 | 742 |
| Movement in net debt in the year | 1,895 | 1,310 |
| Net debt at start of year | 1,563 | 253 |
| Net debt at end of year | 3,458 | 1,563 |
| The net debt comprises | ||
| 31 March 2026 31 March 2025 | ||
| £'000 £'000 | ||
| Cash | 9,241 | 7,403 |
| Current loans | (1,857) | (1,136) |
| Current leases | (352) | (352) |
| Non-current loans | (2,876) | (4,183) |
| Non-current leases | (698) | (169) |
| Net debt at end of year | 3,458 | 1,563 |
Half-year Results, published 23 Dec 25 · read the announcement ↗
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME · FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
| Unaudited 6 months ended 30 September 2025 £'000 | Unaudited 6 months ended 30 September 2024 £'000 | |
|---|---|---|
| Revenue | 11,088 | 19,620 |
| Cost of sales | (6,558) | (12,495) |
| ------------ ------------ | ||
| Gross profit | 4,530 | 7,125 |
| Administrative expenses | (5,596) | (7,313) |
| -------------- -------------- | ||
| Loss from Total Operations | (1,066) | (188) |
| Adjusted EBITDA | (685) | 670 |
| Depreciation & Amortisation | (349) | (807) |
| Share Based Payment | (32) | (51) |
| Exceptional costs | - | - |
| -------------- -------------- | ||
| Loss from Operations | (1,066) | (188) |
| Finance costs | (213) | (152) |
| LLP members remuneration charged as an expense | (548) | (649) |
| ------------ ------------ | ||
| Loss before taxation | (1,827) | (989) |
| Taxation | - | - |
| ------------ ------------ | ||
| Loss Profit after taxation | (1,827) | (989) |
| ------------ ------------ | ||
| Loss after taxation and attributable to equity holders of the Parent and total comprehensive income for the period | (1,827) | (989) |
| ====== ====== | ||
| Loss per share | ||
| Basic | (0.33)p | (0.18)p |
| ====== ====== | ||
| Diluted | (0.31) p | 0.04p |
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION · AS AT 30 SEPTEMBER 2025
| Unaudited 30 September 2025 | Audited 31 March 2025 | |
|---|---|---|
| ASSETS | ||
| Non-current assets | ||
| Tangible fixed assets | 518 | 754 |
| Intangible assets | 20,755 | 20,599 |
| Investments in associates | 5,570 | 7,500 |
| ----------------- ----------------- | ||
| Total non-current assets | 26,843 | 28,853 |
| Current assets | ||
| Trade and other receivables | 22,309 | 17,984 |
| Cash and cash equivalents | 3,675 | 7,403 |
| ----------------- ----------------- | ||
| Total current assets | 25,984 | 25,387 |
| ----------------- ----------------- | ||
| Total assets | 52,827 | 54,240 |
| LIABILITIES | ||
| Current liabilities | (5,646) | (7,396) |
| Non-current liabilities | ||
| Loan & Lease liability | (4,164) | (4,352) |
| Payments due regarding purchase of client lists | (507) | (686) |
| Provisions | (2,235) | (2,565) |
| Deferred taxation | (6) | (1) |
| ------------------ ------------------ | ||
| Total liabilities | (12,558) | (15,000) |
| ------------------ ------------------ | ||
| Total net assets | 40,269 | 39,240 |
| ========= ========= | ||
| Capital and reserves | ||
| Share Capital | 5,602 | 5,602 |
| Treasury Shares | (3,227) | (5,798) |
| Share Premium | 1,828 | 1,828 |
| Capital Redemption Reserve | 534 | 534 |
| Retained Earnings | 35,532 | 37,074 |
| ------------------ ------------------ | ||
| Total equity | 40,269 | 39,240 |
| ========= ========= | ||
| 19 December 2025. | ||
| Johanna Rager | ||
| Finance & Operations Director | ||
| UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY | ||
| FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025 | ||
| £'000 £'000 £'000 £'000 £'000 £'000 | ||
| 31 March 2024 | 32,484 | 40,448 |
| Profit after tax and total comprehensive income | 6,932 | 6,932 |
| Treasury Shares allocation | - | (5,798) |
| Equity settled share-based payments | (234) | (234) |
| Increase in interest of a controlled subsidiary | (550) | (550) |
| Tavistock Protect Adjustment | (529) | (529) |
| Disposal/Closure of subsidiary | (624) | (624) |
| Dividend payment | (405) | (405) |
| 31 March 2025 | 37,074 | 39,240 |
| Loss after tax and total comprehensive income | (1,827) | (1,827) |
| Treasury Shares transfer to EBT | 253 | 2,824 |
| Equity settled share-based payments | 32 | 32 |
| Unaudited 30 September 2025 | 35,532 | 40,269 |
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS · FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
| Unaudited Period ended 30 September 2025 £'000 | Audited Year ended 31 March 2025 £'000 | |
|---|---|---|
| Cash flows from operating activities | ||
| (Loss)/Profit before tax | (1,574) | 6,699 |
| Adjustments for | ||
| Share based payments | 32 | (234) |
| Depreciation on tangible fixed assets | 218 | 605 |
| Amortisation of intangible assets | 132 | 3,336 |
| Regulatory provisions | - | 780 |
| Exceptional costs | (253) | 6,233 |
| Finance income | 213 | 339 |
| Goodwill impairment | - | 5,493 |
| EBT transfer | 2,823 | - |
| Cash received on sale of subsidiary entities | - | (21,360) |
| ----------------- ----------------- | ||
| Cash flows generated from/(used in) operating activities | 1,591 | 1,891 |
| before changes in working capital | ||
| Increase in trade and other receivables | (3,910) | (13,883) |
| (Increase)/Decrease in trade and other creditors | (1,350) | 6,257 |
| ----------------- ----------------- | ||
| Cash used in Operations | (3,669) | (5,735) |
| Investing activities | ||
| Intangible assets - client lists and internally developed assets | (284) | (3,224) |
| Purchase of tangible fixed assets | (18) | (53) |
| Deferred consideration payments | (679) | (705) |
| Minority Interest income/(write down) | 1,930 | (2,679) |
| Acquisition of subsidiary | - | (7,004) |
| Amount owed on acquisition of subsidiary | - | (740) |
| Cash received on sale of subsidiary | - | 21,360 |
| Cash received on acquisition of subsidiary | - | 621 |
| ----------------- ----------------- | ||
| Net cashflow used in investing activities | 949 | 7,576 |
| Financing activities | ||
| Finance costs | (213) | (339) |
| New leases | - | 30 |
| Lease repayment | (217) | (588) |
| New loans | - | 3,275 |
| Loan repayments | (578) | (742) |
| Share based Buybacks | - | 213 |
| Dividend payment | - | (405) |
| EBT Transfer gain | 253 | - |
| ----------------- ----------------- | ||
| Net cashflow generated (used in)/from financing activities | (755) | 1,444 |
| ----------------- ----------------- | ||
| Net change in cash and cash equivalents | (3,728) | 3,285 |
| Cash and cash equivalents at start of period | 7,403 | 4,118 |
| ------------------ ------------------ | ||
| Cash and cash equivalents at end of period | 3,675 | 7,403 |
As published in the company's results announcement: every line, heading and subtotal, read automatically from the text. Figures in brackets are negative; units as stated in the column headings.
Latest report: FY Mar 26 (twelve months to 31 Mar 26), published 24 Sep 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| FY Mar 26 | FY Mar 25 | |
|---|---|---|
| Revenue to operating profit | ||
| Revenue | 23.2 | 32.6 |
| Gross profit | 8.7 | 12.7 |
| Adjusted EBITDA | (2.1) | 1.8 |
| Operating profit | (8.1) | 9.7 |
| Depreciation (owned assets) | 0.6 | 0.6 |
| Amortisation | 0.4 | 3.3 |
| Share-based payments | (0.1) | 0.4 |
| Operating profit to net income | ||
| Finance costs | (0.4) | (0.3) |
| Profit before tax | (8.5) | 6.7 |
| Tax | (0.0) | (0.0) |
| Net income (owners) | (8.6) | 6.7 |
| Per share | ||
| EPS basic | (1.5p) | 1.2p |
| EPS diluted | (1.4p) | 1.1p |
| H2 Mar 26 | H1 Sep 25 | H2 Mar 25 | H1 Sep 24 | |
|---|---|---|---|---|
| Revenue to operating profit | ||||
| Revenue | 12.1 | 11.1 | 13.0 | 19.6 |
| Gross profit | 4.1 | 4.5 | 5.6 | 7.1 |
| Adjusted EBITDA | (1.4) | (0.7) | 1.1 | 0.7 |
| Operating profit | (7.1) | (1.1) | 9.9 | (0.2) |
| Depreciation (owned assets) | 0.4 | 0.2 | – | – |
| Amortisation | 0.3 | 0.1 | – | – |
| Share-based payments | (0.0) | (0.0) | 0.5 | (0.1) |
| Operating profit to net income | ||||
| Finance costs | (0.2) | (0.2) | (0.2) | (0.2) |
| Profit before tax | (6.7) | (1.8) | 7.7 | (1.0) |
| Net income (owners) | (6.7) | (1.8) | 7.7 | (1.0) |
| Per share | ||||
| EPS basic | (1.2p) | (0.3p) | 1.4p | (0.2p) |
| EPS diluted | (1.0p) | (0.3p) | 1.0p | 0.0p |
| H2 Mar 26 | H1 Sep 25 | |
|---|---|---|
| Operating activities | ||
| Cash from operations | (1.3) | (3.7) |
| Investing activities | ||
| Capex (PP&E) | (0.0) | (0.0) |
| Capex (intangibles) | (0.3) | (0.3) |
| Financing activities | ||
| Lease principal paid | (0.2) | (0.2) |
| Dividends paid | (0.4) | 0.0 |
| FY Mar 26 | FY Mar 25 | |
|---|---|---|
| Non-current assets | ||
| Other intangibles | – | 20.6 |
| Property, plant & equipment | 1.1 | 0.8 |
| Associates & JVs | – | 7.5 |
| Non-current assets | 23.8 | 28.9 |
| Current assets | ||
| Trade receivables | 10.6 | 18.0 |
| Cash | 9.2 | 7.4 |
| Current assets | 19.8 | 25.4 |
| Total assets | 43.6 | 54.2 |
| Current liabilities | ||
| Trade payables | 2.9 | 5.9 |
| Borrowings, current | 1.9 | 1.1 |
| Lease liabilities, current | 0.4 | 0.4 |
| Current liabilities | 7.2 | 8.5 |
| Non-current liabilities | ||
| Borrowings, non-current | 2.9 | 4.2 |
| Lease liabilities, non-current | 0.7 | 0.2 |
| Non-current liabilities | 6.1 | 6.5 |
| Total liabilities | 13.3 | 15.0 |
| Equity | ||
| Total equity | 30.4 | 39.2 |
| Net cash and other figures | ||
| Treasury shares | -5.8m | -5.8m |
| H2 Mar 26 | H1 Sep 25 | H2 Mar 25 | |
|---|---|---|---|
| Non-current assets | |||
| Other intangibles | – | 20.8 | 20.6 |
| Property, plant & equipment | 1.1 | 0.5 | 0.8 |
| Associates & JVs | – | 5.6 | 7.5 |
| Non-current assets | 23.8 | 26.8 | 28.9 |
| Current assets | |||
| Trade receivables | 10.6 | 22.3 | 18.0 |
| Cash | 9.2 | 3.7 | 7.4 |
| Current assets | 19.8 | 26.0 | 25.4 |
| Total assets | 43.6 | 52.8 | 54.2 |
| Current liabilities | |||
| Trade payables | 2.9 | – | 5.9 |
| Borrowings, current | 1.9 | – | 1.1 |
| Lease liabilities, current | 0.4 | – | 0.4 |
| Current liabilities | 7.2 | 5.6 | 8.5 |
| Non-current liabilities | |||
| Borrowings, non-current | 2.9 | – | 4.2 |
| Lease liabilities, non-current | 0.7 | – | 0.2 |
| Non-current liabilities | 6.1 | 6.9 | 6.5 |
| Total liabilities | 13.3 | 12.6 | 15.0 |
| Equity | |||
| Total equity | 30.4 | 40.3 | 39.2 |
| Net cash and other figures | |||
| Treasury shares | -5.8m | – | -5.8m |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.